Development of a robust wide field surface plasmon instrument as part of a platform for Alzheimer's disease diagnosis

Abstract

Alzheimer's disease is the most common form of dementia affecting over 830,000 people in the UK. There is currently no cure, but there are treatments available that can slow down the progression of the disease and so developing a method for early diagnosis is very desirable.